Maternal Serum Screening - Quadruple Marker

Service Description

The Quad Marker screening is a prenatal blood test performed during the second trimester (weeks 15–20) to evaluate the risk of chromosomal abnormalities and neural tube defects. It measures four specific proteins and hormones in the mother's blood to provide important health insights for the pregnancy.